Brief: Niagen Bioscience Secures New U.S. Patent For Nicotinamide Riboside
25/02/2026 13:41
Feb 25 (Reuters) - Niagen Bioscience Inc NAGE.O: NIAGEN BIOSCIENCE INC - SECURES NEW U.S. PATENT FOR INTRAVENOUS AND INJECTION FORMULATIONS & METHODS OF USE FOR NICOTINAMIDE RIBOSIDE Source text: ID:nBw6s7v9Ra Further company coverage: NAGE.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce